According to a recent informal poll of Healthcare Packaging (HCP) readers, half the respondents agreed that packaging should enter the stream at the beginning of the clinical trial. An encouraging number, considering the metamorphosis the primary package will likely undergo as the drug formulation continues to change during the course of the trial.

While some companies may be actively seeking the value proposition of RFID implementation, others have discovered that the value proposition already exists in applications utilizing active RFID.

The purpose of this website is to present the status of development of a wide variety of portable electronic medication monitors that could be used to supervise the self-administered treatment of tuberculosis and perhaps AIDS. The discussion includes both commercially available devices and various designs of potential medication monitors, to allow investigators and funding sources to chose the optimal device for their needs and encourage inventors to develop improvements.

Guidelines for Temperature Control of Drug Products during Storage and Transportation

Med-ic ECM technology records patient adherence to correlate critical bloodwork

Med-ic RFID smart sensor labels will monitor over 250,000 doses in a large Phase II clinical trial to be conducted in Europe over the next 6 months. IMC has already delivered 6,000 self-adhesive smart labels to Aptuit, the study’s packaging supplier.